Factors Associated with Severe COVID-19 Among Patients with Rheumatoid Arthritis: A Large, Nationwide Electronic Health Record Cohort Study in the United States.
Yizhou YeXiaomeng YueWhitney S KruegerLani R WegrzynAnna W ManicciaKevin L WinthropSeoyoung C KimPublished in: Advances in therapy (2023)
Nearly one in five patients with RA developed severe COVID-19 disease within 30 days after SARS-CoV-2 infection. In patients with RA, recent use of corticosteroids and rituximab were two factors associated with a greater risk of severe COVID-19 in addition to the risk factors among demographics and comorbidities previously identified in the general population.
Keyphrases
- coronavirus disease
- sars cov
- electronic health record
- risk factors
- respiratory syndrome coronavirus
- early onset
- rheumatoid arthritis
- disease activity
- drug induced
- ankylosing spondylitis
- interstitial lung disease
- clinical decision support
- systemic lupus erythematosus
- systemic sclerosis
- hodgkin lymphoma
- chronic lymphocytic leukemia